ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Unlock Practice Growth: Experience cvi42 at RSNA 2025

Highlights

  • The latest release of cvi42 v6.4 focuses on workflow efficiency and leveraging artificial intelligence
  • In-house post-processing speeds reporting time and captures more reimbursement
  • Circle’s vascular capabilities expand with the addition of cvi42 | Vascular CT
  • New business models increase the flexibility and accessibility for reporting physicians

CALGARY, Alberta, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Circle Cardiovascular Imaging (Circle CVI), the market leader in cardiovascular imaging post-processing will unveil its latest release at the Radiological Society of North America (RSNA) Annual General Meeting being held November 30 – December 4 in Chicago, IL. Circle CVI will demonstrate its newest release, cvi42 v6.4.

Radiology leaders know that efficiency, accuracy, and practice growth are non-negotiable. At RSNA 2025, Circle Cardiovascular Imaging invites you to experience the new cvi42 release - a solution engineered to grow your CCT and CMR business.

What cvi42 can do for your practice:

  • Reduce Reporting Times:
    Native integration with PowerScribe automates transcription, minimizing error risk and freeing clinical teams to focus on interpretation rather than manual data entry.
  • Accelerate Patient Care:
    In-house plaque analysis with cvi42 enables faster turnaround times, supporting timely diagnosis and allowing you to deliver a higher standard of care.
  • Drive Confidence and Adoption:
    cvi42 | Vascular CT follows best practices with automated contouring, lowering barriers to using advanced CT vascular analysis - so teams adopt new capabilities faster.
  • Increase Revenue Capture:
    With cvi42 | Plaque you pay for what you process at a fraction of the price of outsourcing and increase your throughput with a streamlined workflow.
  • Elevate Value and Flexibility:
    Our new subscription model provides scalable access to CMR and CCT functionalities ensuring your team has unlimited access to work from anywhere.

“With our latest cvi42 release, we’re helping practices unlock greater efficiency, deliver faster patient care, and build a scalable foundation for the future of cardiovascular imaging while supporting business growth” said Chris Bazinet, Chief Revenue Officer of Circle CVI. “We are excited to see how our customers respond to the latest innovations and hear from them how we are solving their challenges”

Benefits for Radiology Leaders and Decision Makers:

  • Minimized risk of error in reporting
  • Improved workflow efficiency, leading to reduced burnout
  • Faster reporting speeds, translating to greater practice performance
  • Flexibility to scale and capture new revenue streams
  • Technology that aligns with evolving best practices and reimbursement guidelines

Join Us at RSNA 2025 - Shape the Future of Cardiovascular Imaging
Nov. 30 – Dec. 3 | Booth #7961, North Hall
Secure your demo now - see how cvi42 can help you lead with confidence and results.

[Save me a spot!]


Enquiries
  

Circle Marketing
marketing@circlecvi.com

ABOUT CIRCLE CARDIOVASCULAR IMAGING
Circle Cardiovascular Imaging Inc. (Circle CVI) is a Canadian-based company founded in 2007 with a mission to develop innovative software solutions that enhance cardiovascular and cerebrovascular imaging analysis and ultimately improve patient care. Circle’s flagship platform, cvi42, delivers best-in-class image reading and reporting tools for quantitative and qualitative assessment of cardiac MR, cardiac CT, vascular CT, and neuro CT.

At the core of Circle’s work is a relentless commitment to empowering healthcare providers with advanced, intuitive tools that lead to better healthcare outcomes. This passion for innovation, rooted in both medicine and technology, drives Circle’s global impact and fuels a culture of excellence.

Today, millions of medical imaging exams each year—across 1,700+ hospitals in over 90 countries—are interpreted using Circle’s cvi42 platform.
For more information, please visit www.circlecvi.com or contact: marketing@circlecvi.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.87
-5.33 (-2.48%)
AAPL  249.94
-4.29 (-1.69%)
AMD  199.46
+3.15 (1.60%)
BAC  46.83
-0.45 (-0.95%)
GOOG  306.30
-3.11 (-1.01%)
META  615.68
-6.98 (-1.12%)
MSFT  391.67
-7.74 (-1.94%)
NVDA  180.40
-1.53 (-0.84%)
ORCL  152.90
-1.79 (-1.16%)
TSLA  392.78
-6.49 (-1.63%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.